Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.
Botulinum Toxins, Type A
/ adverse effects
Consensus
Contusions
/ chemically induced
Cosmetic Techniques
/ adverse effects
Dermal Fillers
/ adverse effects
Directive Counseling
Edema
/ chemically induced
Erythema
/ chemically induced
Face
Hematoma
/ chemically induced
Humans
Hyaluronic Acid
/ adverse effects
Injection Site Reaction
/ etiology
Injections
/ adverse effects
Neuromuscular Agents
/ adverse effects
Pain
/ chemically induced
Patient Education as Topic
Patient Selection
botulinum toxin
dermal fillers
hyaluronic acid
neuromodulators
rejuvenation
Journal
The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
02
10
2019
revised:
03
02
2020
accepted:
19
02
2020
pubmed:
24
3
2020
medline:
6
7
2021
entrez:
24
3
2020
Statut:
ppublish
Résumé
Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes. As with any medical treatment, adverse events and complications may occur. Adverse events associated with these products are typically transient and mild to moderate in severity. Serious adverse events, such as infection and intravascular occlusion, are rare. Proper patient selection, consent and counselling, preparation and impeccable injection technique are important risk reduction strategies. Both clinicians and patients must be alert to the signs and symptoms of complications so that appropriate treatment can be started promptly. In this article, the authors review the current literature and provide their consensus recommendations for minimising adverse outcomes when treating patients with botulinum toxin or hyaluronic acid fillers.
Identifiants
pubmed: 32201935
doi: 10.1111/ajd.13273
pmc: PMC7497045
doi:
Substances chimiques
Dermal Fillers
0
Neuromuscular Agents
0
Hyaluronic Acid
9004-61-9
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
217-225Informations de copyright
© 2020 The Authors. Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.
Références
Aesthet Surg J. 2014 May 1;34(4):584-600
pubmed: 24692598
J Clin Aesthet Dermatol. 2018 May;11(5):E53-E55
pubmed: 29785240
Plast Reconstr Surg. 2014 Dec;134(6):1197-201
pubmed: 25415089
Aesthetic Plast Surg. 2016 Aug;40(4):549-55
pubmed: 27286849
J Am Acad Dermatol. 2009 Dec;61(6):961-70.e1-11
pubmed: 19744746
J Am Acad Dermatol. 2018 Sep;79(3):407-419
pubmed: 30119865
Aesthet Surg J. 2020 Aug 14;40(9):1009-1021
pubmed: 31693068
Am J Clin Dermatol. 2013 Oct;14(5):401-11
pubmed: 24037757
Br Dent J. 2009 Sep 12;207(5):E9; discussion 216-7
pubmed: 19749689
J Clin Aesthet Dermatol. 2011 Oct;4(10):28-34
pubmed: 22010053
Aesthet Surg J. 2011 Nov;31(8):966-71
pubmed: 22001341
Cutis. 2016 Nov;98(5):309-313
pubmed: 28040813
Dermatol Surg. 2015 Oct;41(10):1149-57
pubmed: 26359996
Plast Reconstr Surg. 2017 Mar;139(3):613-621
pubmed: 28234833
Clin Cosmet Investig Dermatol. 2013 Dec 12;6:295-316
pubmed: 24363560
Aesthetic Plast Surg. 2014 Apr;38(2):413-8
pubmed: 24464122
J Am Acad Dermatol. 2018 Sep;79(3):423-435
pubmed: 30119866
Dermatol Surg. 2018 Jan;44(1):53-60
pubmed: 28538034
Dermatol Surg. 2013 Apr;39(4):551-8
pubmed: 23379292
Dermatol Surg. 2018 Dec;44(12):1555-1564
pubmed: 30204739
Clin Cosmet Investig Dermatol. 2015 Apr 15;8:205-14
pubmed: 25926750
Aesthet Surg J. 2019 May 16;39(6):662-674
pubmed: 30805636
Dermatol Surg. 2014 May;40(5):525-36
pubmed: 24575858
Aesthetic Plast Surg. 2017 Jun;41(3):667-677
pubmed: 28411354
J Oral Maxillofac Surg. 2017 Jan;75(1):160-166
pubmed: 27717817
Plast Reconstr Surg. 2015 Nov;136(5 Suppl):196S-203S
pubmed: 26441099
Dermatol Surg. 2018 Apr;44(4):597-599
pubmed: 28872560
Plast Reconstr Surg. 2017 Aug;140(2):265e-276e
pubmed: 28746271
Lancet. 1993 Dec 18-25;342(8886-8887):1548-9
pubmed: 7902913
Dermatol Surg. 2015 Oct;41(10):1097-117
pubmed: 26356847
Plast Reconstr Surg. 2015 Nov;136(5 Suppl):219S-234S
pubmed: 26441102
Plast Reconstr Surg. 2015 Nov;136(5 Suppl):235S-257S
pubmed: 26441104
Facial Plast Surg. 2014 Apr;30(2):152-6
pubmed: 24810126
Plast Reconstr Surg. 2019 Mar;143(3):504e-512e
pubmed: 30589824
J Am Acad Dermatol. 2017 Jun;76(6):1027-1042
pubmed: 28522039
Pathog Dis. 2014 Apr;70(3):339-46
pubmed: 24482426
Am Fam Physician. 2014 Aug 1;90(3):168-75
pubmed: 25077722
Dermatol Surg. 2018 Mar;44(3):435-437
pubmed: 28877147
Dermatol Surg. 2016 Jan;42(1):31-7
pubmed: 26655699
J Am Acad Dermatol. 2012 Sep;67(3):373-8
pubmed: 22055283
J Oral Maxillofac Surg. 2017 Dec;75(12):2667.e1-2667.e5
pubmed: 28923273
JAMA Facial Plast Surg. 2013 May;15(3):226-31
pubmed: 23539246
Dermatol Surg. 2017 Jan;43(1):1-6
pubmed: 27399954
Clin Dermatol. 2011 Nov-Dec;29(6):678-90
pubmed: 22014990
Plast Reconstr Surg. 2016 Jun;137(6):961e-71e
pubmed: 27219265
J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1088-1095
pubmed: 28449190
J Drugs Dermatol. 2016 Dec 1;15(12):1524-1531
pubmed: 28095575
Plast Reconstr Surg. 2016 Mar;137(3):518e-529e
pubmed: 26910696
J Oral Maxillofac Surg. 2016 Aug;74(8):1630-6
pubmed: 27067061
Plast Reconstr Surg. 2016 May;137(5):1410-23
pubmed: 27119917
Dermatol Surg. 2016 Apr;42(4):547-9
pubmed: 26981723
Tuberc Respir Dis (Seoul). 2014 Aug;77(2):90-3
pubmed: 25237381